Australia · Delayed Price · Currency is AUD SciDev Statistics
Total Valuation
SciDev has a market cap or net worth of AUD 45.62 million. The enterprise value is 43.45 million.
| Market Cap | 45.62M |
| Enterprise Value | 43.45M |
Important Dates
The last earnings date was Sunday, February 22, 2026.
| Earnings Date | Feb 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SciDev has 190.09 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 190.09M |
| Shares Outstanding | 190.09M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 12.96% |
| Owned by Institutions (%) | 30.01% |
| Float | 122.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.26 |
| PS Ratio | 0.45 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.32, with an EV/FCF ratio of -20.38.
| EV / Earnings | -14.73 |
| EV / Sales | 0.43 |
| EV / EBITDA | 12.32 |
| EV / EBIT | n/a |
| EV / FCF | -20.38 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.51 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.52 |
| Debt / FCF | -2.51 |
| Interest Coverage | -0.09 |
Financial Efficiency
Return on equity (ROE) is -5.95% and return on invested capital (ROIC) is -0.10%.
| Return on Equity (ROE) | -5.95% |
| Return on Assets (ROA) | -0.04% |
| Return on Invested Capital (ROIC) | -0.10% |
| Return on Capital Employed (ROCE) | -0.09% |
| Weighted Average Cost of Capital (WACC) | 10.09% |
| Revenue Per Employee | 4.62M |
| Profits Per Employee | -134,091 |
| Employee Count | 22 |
| Asset Turnover | 1.38 |
| Inventory Turnover | 8.77 |
Taxes
In the past 12 months, SciDev has paid 1.49 million in taxes.
| Income Tax | 1.49M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.86% in the last 52 weeks. The beta is 1.11, so SciDev's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -42.86% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.36 |
| Relative Strength Index (RSI) | 26.01 |
| Average Volume (20 Days) | 259,635 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SciDev had revenue of AUD 101.58 million and -2.95 million in losses. Loss per share was -0.02.
| Revenue | 101.58M |
| Gross Profit | 30.24M |
| Operating Income | -47,000 |
| Pretax Income | -1.46M |
| Net Income | -2.95M |
| EBITDA | 2.28M |
| EBIT | -47,000 |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 7.52 million in cash and 5.35 million in debt, with a net cash position of 2.17 million or 0.01 per share.
| Cash & Cash Equivalents | 7.52M |
| Total Debt | 5.35M |
| Net Cash | 2.17M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 47.43M |
| Book Value Per Share | 0.25 |
| Working Capital | 10.69M |
Cash Flow
In the last 12 months, operating cash flow was -1,000 and capital expenditures -2.13 million, giving a free cash flow of -2.13 million.
| Operating Cash Flow | -1,000 |
| Capital Expenditures | -2.13M |
| Free Cash Flow | -2.13M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 29.77%, with operating and profit margins of -0.05% and -2.90%.
| Gross Margin | 29.77% |
| Operating Margin | -0.05% |
| Pretax Margin | -1.44% |
| Profit Margin | -2.90% |
| EBITDA Margin | 2.25% |
| EBIT Margin | -0.05% |
| FCF Margin | n/a |
Dividends & Yields
SciDev does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.10% |
| Shareholder Yield | -0.10% |
| Earnings Yield | -6.47% |
| FCF Yield | -4.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 3, 2018. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 3, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
SciDev has an Altman Z-Score of 2.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 2 |